Evita

So, does anyone feel sorry for Pfizer after they had to recall all of that Liptor last week? 191,000 bottles of Lipitor has a ‘street value’ of over 31 million dollars – surely this has to effect Pfizer's bottom line?

Probably not. Since it was the bottles that were bad, and not the pills inside, they most likely can just repackage the pills – if the FDA lets them, that is. Even if they can’t repackage the pills and have to toss them out (or ship them overseas to a country with less stringent drug purity laws) Pfizer shouldn’t be troubled by the 31 million dollar loss.

You see, Lititor is the A-Rod of prescription drugs – a bonafide superstar – numero uno on the prescription drug hit parade. Last year alone, Lipitor racked up over 11 billion (with a B) dollars in sales. So a measly 31 million shouldn’t even be noticed by the bean-counters at Pfizer – they can just chalk it up to a rounding error.

Which makes me wonder – why does Lipitor come in the form of a a dull white pill? They should make the pills in a nice shade of American green.





***** Found this Interesting, Entertaining or Informative? Please read the complete blog at: *****
http://healthcarehullabalo.blogspot.com/


Free Blog Counter